Nebula Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.25 Cr
as on 17-07-2024
- Revenue 14.64%
(FY 2023)
- Profit -11.41%
(FY 2023)
- Ebitda 7.70%
(FY 2023)
- Net Worth 87.63%
(FY 2023)
- Total Assets 2.33%
(FY 2023)
About Nebula Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹4.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ketankumar Dhamsania, Miralgauri Dhamsania, Champaben Dhamsania, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999GJ2018PLC102425
- Company No.
102425
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 May 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Kadi, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nebula Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ketankumar Dhamsania  | Director | 18-May-2018 | Current |
| Miralgauri Dhamsania | Director | 18-May-2018 | Current |
| Champaben Dhamsania | Director | 18-Feb-2021 | Current |
| Maganlal Dhamsania | Director | 18-May-2018 | Current |
Financial Performance of Nebula Healthcare.
Nebula Healthcare Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.64% increase. The company also saw a substantial fall in profitability, with a 11.41% decrease in profit. The company's net worth Soared by an impressive increase of 87.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nebula Healthcare?
In 2023, Nebula Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nolvox Pharma Private LimitedActive 2 years 9 monthsKetankumar Dhamsania and Maganlal Dhamsania are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Mar 2021 | ₹4.25 Cr | Satisfied |
How Many Employees Work at Nebula Healthcare?
Nebula Healthcare has a workforce of 6 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nebula Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nebula Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
